National Guideline Clearinghouse | Eribulin for the treatment of locally advanced or metastatic breast cancer.

National Institute for Health and Clinical Excellence (NICE). ► full-text:
National Guideline Clearinghouse | Eribulin for the treatment of locally advanced or metastatic breast cancer.

Guideline Title

Eribulin for the treatment of locally advanced or metastatic breast cancer.

 

 

Bibliographic Source(s)

National Institute for Health and Clinical Excellence (NICE). Eribulin for the treatment of locally advanced or metastatic breast cancer. London (UK): National Institute for Health and Clinical Excellence (NICE); 2012 Apr. 67 p. (Technology appraisal guidance; no. 250).

 

 

Guideline Status

This is the current release of the guideline.